FDA Announces Recall of Labetalol Hydrochloride Injection: AttorneyOne Monitor and Keep Consumers Informed

On May 16, the FDA announced that one lot of Labetalol Hydrochloride Injection 100Mg/20 ML (5MG/ML), 20 ML, Multidose Vial by Hospira is recalled due to visible particulates. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Labetalol Hydrochloride Injection Recall

Labetalol Hydrochloride Injection Recall

we are determined to keep an eye on FDA announcements concerning Labetalol Hydrochloride Injection and inform the public

San Diego, CA (PRWEB) May 26, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Labetalol Hydrochloride Injection.

The FDA announced on May 16, that one lot of Labetalol Hydrochloride Injection 100Mg/20 ML (5MG/ML), 20 ML, Multidose Vial by Hospira is recalled due to embedded particulate within the glass vial identified as stainless steel and visible particles floating in the solution identified as as iron oxide.

Administration of this drug may cause injection site reactions and local irritation in the blood vessels, tissues and organs. In addition, exposure of the particulate to strong magnetic fields could cause tissue damage, according to the FDA.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning Labetalol Hydrochloride Injection and inform the public. For that reason," he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

As the FDA advises “Anyone with an existing inventory should immediately stop use and quarantine any affected product. In addition, customers should inform potential users of this product in their organizations of this notification.” And the Agency adds “For medical inquiries, please contact Hospira Medical Communications.”

AttorneyOne.com has further information on Labetalol Hydrochloride Injection at the website including latest major drug and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/05/prweb11879305.htm